From Medscape Rheumatology

Coverage from the

European Alliance of Associations for Rheumatology (EULAR) 2023 Annual Meeting

May 31 - June 03, 2023; Milan, Italy

May 31 - June 03, 2023 Milan, Italy

EULAR 2023 Two Biologics Show No Difference in Axial Spondyloarthritis This study represents the first head-to-head trial comparing the effects of two biologics in axial spondyloarthritis, in this case in patients at high risk for radiographic progression.
Medscape Medical News, June 1, 2023
EULAR 2023 Lupus Nephritis: Hopes, Questions Arise for Baricitinib Results from a small, independently funded, double-blind, active-comparator trial suggest that baricitinib could be beneficial in the treatment of lupus nephritis.
Medscape Medical News, June 1, 2023

Conference News

Systemic JIA and AOSD Are the Same Disease, EULAR Says
Medscape Medical News, June 16, 2023
EULAR 2023 EULAR Issues Imaging Recommendations for Gout, CPPD
Medscape Medical News, June 16, 2023
EULAR 2023 Latest Data: COVID Vax in Inflammatory, Autoimmune Diseases
Medscape Medical News, June 15, 2023
EULAR 2023 EULAR Lupus Recommendations: Use Biologics, Taper Steroids
MDedge News, June 14, 2023
EULAR 2023 Romosozumab Tops Denosumab in Treating GIOP
Medscape Medical News, June 12, 2023
EULAR 2023 CVD Risk Tools Are Less Accurate in Patients With Arthritis
Medscape Medical News, June 12, 2023
EULAR 2023 HIIT Has Sustainable Effects in Inflammatory Arthritis
Medscape Medical News, June 9, 2023
EULAR 2023 Dazodalibep May Mitigate Sjögren Syndrome
Medscape Medical News, June 9, 2023
EULAR 2023 EULAR PsA Update Emphasizes Safety, Non-MSK Manifestations
Medscape Medical News, June 9, 2023
Long COVID Risk Not Higher With Rheumatic Diseases
Medscape Medical News, June 7, 2023
EULAR 2023 Uricase-Based Gout Drug Meets Endpoints in Phase 3 Trials
MDedge News, June 7, 2023

EULAR 2023 Nuances in Efficacy, MACE Risk Revealed Between JAKi, TNFi
Medscape Medical News, June 7, 2023
EULAR 2023 Early AxSpA Diagnosis Stable in Most Referred Patients
Medscape Medical News, June 5, 2023
EULAR 2023 EULAR SSc Recommendations Now Include Immunosuppressants
MDedge News, June 5, 2023
EULAR 2023 URAT1 Inhibitor Shows 'Substantial' Cut in Uric Acid in Gout
MDedge News, June 5, 2023
EULAR 2023 RA and Demyelinating Disease: No Consistent Link to TNFi
Medscape Medical News, June 5, 2023
EULAR 2023 AI Efforts Make Strides in Predicting Progression to RA
Medscape Medical News, June 2, 2023
EULAR 2023 Promising Telitacicept Results Reported for Lupus, Sjögren's
MDedge News, June 2, 2023
EULAR 2023 ILD Risk Elevated in RA, PsA After Starting DMARDs
MDedge News, June 1, 2023
EULAR 2023 Two Biologics Show No Difference in Axial Spondyloarthritis
Medscape Medical News, June 1, 2023
EULAR 2023 Lupus Nephritis: Hopes, Questions Arise for Baricitinib
Medscape Medical News, June 1, 2023

Popular News From EULAR 2022

EULAR RA Recommendations: Start Methotrexate, Steroids First Contrary to ACR guidance, EULAR recommends starting methotrexate and glucocorticoids but dose reduction and discontinuation are emphasized.
Medscape Medical News, Jun 06, 2022
Methotrexate's First Evidence of Disease Modification in Pre-RA Short-term methotrexate used in patients with arthralgia sustainably reduced disease burden and inflammation on MRI in all at-risk groups, according to the first data on pre-RA disease modification.
Medscape Medical News, Jun 06, 2022
Deucravacitinib and Orelabrutinib Perform Well in Lupus Trials Disease activity was reduced by treatment with either of the novel investigational agents in two separate early clinical trials, with further trials planned.
Medscape Medical News, Jun 10, 2022

Medscape Rheumatology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage

Related Coverage